Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing

Nat Rev Drug Discov. 2023 Mar;22(3):165-166. doi: 10.1038/d41573-023-00014-y.
No abstract available

Publication types

  • News

MeSH terms

  • Carcinogenicity Tests
  • DNA Damage*
  • High-Throughput Nucleotide Sequencing*
  • Humans